Retatrutide appears to be a new treatment in the fight against obesity. This novel drug, belonging to a dual GLP-1 and GIP receptor agonist, shows promising results in clinical trials. By activating these receptors, https://tedmyrd088857.thezenweb.com/setmelanotide-a-promising-new-treatment-for-obesity-74359770